| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |